Uncategorized

Short answer: the FDA regulatory pathway for medical devices depends on risk, intended use, and whether a similar device already exists. The three main pathways are: 510(k) – for devices that are substantially equivalent to an existing legally marketed device De Novo – for novel, low-to-moderate risk devices with no predicate

Hard reality: experienced investors can tell—often within minutes—when regulatory strategy was bolted on late instead of built in early. You don’t need to say “we figured […]

How rushing to close issues creates shallow solutions—and repeat failures Speed is often praised in regulated environments. Fast responses look decisive. Quick closures look efficient. Leaders […]

(And What Regulators Are Actually Looking For) The Everyday Problem A safety issue shows up during testing.The team investigates, applies a fix, and documents the decision. […]